Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD
BACKGROUND: Most guidelines recommend either a long-acting beta-agonist (LABA) plus an inhaled glucocorticoid or a long-acting muscarinic antagonist (LAMA) as the first-choice treatment for patients with chronic obstructive pulmonary disease (COPD) who have a high risk of exacerbations. The role of...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2016
|
| Sorozat: | NEW ENGLAND JOURNAL OF MEDICINE
374 No. 23 |
| Tárgyszavak: | |
| doi: | 10.1056/NEJMoa1516385 |
| mtmt: | 3410690 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/29987 |